GALILEO CONSULTING GROUP, INC. for AMERICAN UROGYNECOLOGIC SOCIETY
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FY 2024 Federal Funding for the National Institutes of Health, including the National Institute of Child Health and Human Development (NICHD) and the National Institute for Diabetes, Digestive and Kidney Diseases (NIDDK), FY 2024 Further Consolidated Appropriations Act, HR 2882/P.L. 118-47; FY 2025 - Federal Funding for the National Institutes of Health, including National Institute of Child Health and Human Development (NICHD) and the Office of Research on Womens Health - Report Language Submissions regarding research connected to pregnancy and pelvic organ prolapse and a research plan for epidemiology research on health disparities and pelvic floor disorders . - House and Senate Appropriations Committees.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JILL RATHBUN | — |
Medicare/Medicaid MMM
FY 2024 Consolidated Appropriations Act, HR 4366/P.L. 118-42 - Medicare physician fee schedule conversion factor for 2024; Discussions with House and Senate Offices regarding the future of Medicare physician payment and the Medicare physician payment fee schedule.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JILL RATHBUN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.